FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

5651811000001104: Ursodeoxycholic acid 250mg capsules 100 capsule (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
22816501000001111 Ursodeoxycholic acid 250mg capsules 100 capsule (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
22816601000001110 Ursodeoxycholic acid 250mg capsules 100 capsule en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module


6 descendants. Search Descendants:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Ursodeoxycholic acid 250mg capsules 100 capsule Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Ursodeoxycholic acid 250mg capsules 100 capsule Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Ursodeoxycholic acid 250mg capsules 100 capsule Is pack of Product containing precisely ursodeoxycholic acid 250 milligram/1 each conventional release oral capsule false Inferred relationship Existential restriction modifier
Ursodeoxycholic acid 250mg capsules 100 capsule Has active ingredient Ursodeoxycholic acid false Inferred relationship Existential restriction modifier
Ursodeoxycholic acid 250mg capsules 100 capsule VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Ursodeoxycholic acid 250mg capsules 100 capsule VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Ursodeoxycholic acid 250mg capsules 100 capsule Has manufactured dose form Capsule false Inferred relationship Existential restriction modifier
Ursodeoxycholic acid 250mg capsules 100 capsule Has VMP Product containing precisely ursodeoxycholic acid 250 milligram/1 each conventional release oral capsule true Inferred relationship Existential restriction modifier
Ursodeoxycholic acid 250mg capsules 100 capsule Has specific active ingredient Ursodeoxycholic acid true Inferred relationship Existential restriction modifier
Ursodeoxycholic acid 250mg capsules 100 capsule Has dispensed dose form Capsule true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Ursofalk 250mg capsules (Dr Falk Pharma UK Ltd) 100 capsule 10 x 10 capsules Is a True Ursodeoxycholic acid 250mg capsules 100 capsule Inferred relationship Existential restriction modifier
Ursodeoxycholic acid 250mg capsules (A A H Pharmaceuticals Ltd) 100 capsule Is a True Ursodeoxycholic acid 250mg capsules 100 capsule Inferred relationship Existential restriction modifier
Ursofalk 250mg capsules (Mawdsley-Brooks & Company Ltd) 100 capsule Is a True Ursodeoxycholic acid 250mg capsules 100 capsule Inferred relationship Existential restriction modifier
Ursofalk 250mg capsules (Doncaster Pharmaceuticals Ltd) 100 capsule Is a True Ursodeoxycholic acid 250mg capsules 100 capsule Inferred relationship Existential restriction modifier
Ursofalk 250mg capsules (Lexon (UK) Ltd) 100 capsule Is a True Ursodeoxycholic acid 250mg capsules 100 capsule Inferred relationship Existential restriction modifier
Ursofalk 250mg capsules (Waymade Healthcare Plc) 100 capsule Is a True Ursodeoxycholic acid 250mg capsules 100 capsule Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start